Kayla Johnson



Education and Clerkships

J.D., Southern Methodist University Dedman School of Law, 2017, summa cum laude; Order of the Coif; SMU Law Review

B.A., University of Oklahoma, 2012


Texas, 2017


Kayla Johnson is an associate in the Healthcare and Life Sciences Practice Group in the Dallas office of Haynes and Boone. Her practice focuses primarily on transactional and regulatory healthcare matters. She advises clients on a wide range of unique issues regarding compliance with complex healthcare laws without stifling clients’ innovation or their business objectives.

Before going to law school, Kayla taught high school English as a Teach for America Corps member. In law school, she was awarded SMU Dedman School of Law’s Don M. Smart Directed Research Award for a comprehensive research paper she authored regarding the physician-hospital relationship, credentialing, and the role of medical staff bylaws in today’s healthcare environment. She also studied, and wrote extensively about, bioethics issues and the legal framework for addressing them at the state (Texas) and federal level.

Kayla routinely advises on matters involving key regulatory areas, including the Stark Law; the Anti-Kickback Statute; state fraud and abuse laws; the Sunshine Act; state examining board rules; the Administrative Procedure Act; and FDA drug compounding laws, among a number of others. In doing so, she has added critical regulatory insight to a number of transactional operations and compliance reviews and helped clients address obstacles and navigate through the often overlapping state and federal healthcare laws.

In addition to her healthcare experience, Kayla has assisted with a number of evolving FDA regulatory issues, specifically focusing on marketing and labeling requirements as applicable to restaurant chains, retailers, cosmetics, and other consumer products.


Health Law Vitals

Health Law Vitals - A Healthcare Newsletter from Haynes and Boone

The Haynes and Boone Health Law Vitals Newsletter explores significant developments and legislation in healthcare law. This edition discusses healthcare hazards involving medical records during bankruptcy, a ninth circuit decision that impacts settling FCA defendants, an update on telehealth in Texas, and guidance on how to avoid FCA liability for firms investing in healthcare companies.



The Extension of the Texas 1115 Waiver – What is Next?

The Centers for Medicare & Medicaid Services approved another extension of the 1115(a) demonstration project, “Texas Healthcare Transformation and Quality Improvement Program” (2017 Waiver) for an additional five-year term from October 2017 to September 2022.



How Should Restaurants Handle and Declare Major Food Allergens?

Although many restaurants are not in states that require food allergens to be declared on menus, the declaration (or labeling) and handling of food allergens is a growing concern for restaurants, due to the significant risks of liability and poor public relations, if handled incorrectly.

Selected Client Representations

  • Provide regulatory guidance regarding the legal framework governing physician drug compounding.
  • Review, revise, and draft In-Hospital Do-Not-Resuscitate Orders and Consents in compliance with (at-the-time) newly enacted state Health and Safety Code provisions.
  • Perform comprehensive state and federal regulatory analyses and provide compliance advice in connection with numerous operational endeavors proposed by healthcare entities.
  • Review and revise patient paperwork and internal policies for physician groups and other healthcare entities.
  • Provide guidance regarding provider enrollment and claim submission requirements in relation to Medicare, Medicaid, CHIP, TriCare, and Medicare Advantage.
  • Conduct surveys of state laws applicable to individual and corporate providers, including those related to patient abandonment, informed consent, and the corporate practice of medicine.
  • Advise restaurant chains and retailers regarding FDA menu labeling requirements.
  • Conduct due diligence in connection with mergers and acquisitions involving food manufacturing facilities to determine level of compliance with state and local permit/license requirements.

Email Disclaimer